PortfoliosLab logoPortfoliosLab logo
CNCR vs. PINK
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

CNCR vs. PINK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and Simplify Health Care ETF (PINK). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CNCR vs. PINK - Yearly Performance Comparison


Returns By Period


CNCR

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*

PINK

1D
0.59%
1M
-6.30%
YTD
-7.35%
6M
5.14%
1Y
18.61%
3Y*
11.27%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CNCR vs. PINK - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than PINK's 0.50% expense ratio.


Return for Risk

CNCR vs. PINK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNCR

PINK
PINK Risk / Return Rank: 4141
Overall Rank
PINK Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
PINK Sortino Ratio Rank: 4949
Sortino Ratio Rank
PINK Omega Ratio Rank: 4040
Omega Ratio Rank
PINK Calmar Ratio Rank: 3535
Calmar Ratio Rank
PINK Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. PINK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and Simplify Health Care ETF (PINK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

CNCR vs. PINK - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


CNCRPINKDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.91

Sharpe Ratio (All Time)

Calculated using the full available price history

0.44

Dividends

CNCR vs. PINK - Dividend Comparison

CNCR has not paid dividends to shareholders, while PINK's dividend yield for the trailing twelve months is around 0.74%.


TTM20252024202320222021
CNCR
Loncar Cancer Immunotherapy ETF
0.00%0.00%0.00%0.00%0.00%0.00%
PINK
Simplify Health Care ETF
0.74%0.68%0.32%0.94%0.42%0.04%

Drawdowns

CNCR vs. PINK - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum PINK drawdown of -18.77%. Use the drawdown chart below to compare losses from any high point for CNCR and PINK.


Loading graphics...

Drawdown Indicators


CNCRPINKDifference

Max Drawdown

Largest peak-to-trough decline

0.00%

-18.77%

+18.77%

Max Drawdown (1Y)

Largest decline over 1 year

-16.81%

Current Drawdown

Current decline from peak

0.00%

-12.08%

+12.08%

Average Drawdown

Average peak-to-trough decline

0.00%

-6.73%

+6.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.86%

Volatility

CNCR vs. PINK - Volatility Comparison


Loading graphics...

Volatility by Period


CNCRPINKDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.40%

Volatility (6M)

Calculated over the trailing 6-month period

13.96%

Volatility (1Y)

Calculated over the trailing 1-year period

0.00%

20.58%

-20.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

0.00%

17.57%

-17.57%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

0.00%

17.57%

-17.57%